ライフサイエンスコーパス: intratracheal administration

1 mor tissues persisted at least 14 days after intratracheal administration.

2 mor-targeted gene delivery in the setting of intratracheal administration.

3 ion, specifically in the upper airways after intratracheal administration.

4 vivo models in two species via intranasal or intratracheal administration.

5 profile with no signs of toxicity following intratracheal administration.

6 Sixteen rats were studied 3 days after an intratracheal administration of 5 x 10(9) to 1 x 10(11)

7 Intratracheal administration of a monoclonal Fas-activat

8 The intratracheal administration of a perfluorocarbon liquid

9 In cyclophosphamide-treated animals, intratracheal administration of a TNF-alpha agonist pept

10 Furthermore, intratracheal administration of Ad-Stat3-EVA caused sign

11 acute inflammatory responses in the lung to intratracheal administration of Ad.

12 Intratracheal administration of Ad5-HO-1 resulted in a t

13 After intratracheal administration of AdCMVbetagal, expression

14 One day after intratracheal administration of AdCMVeNOS to eNOS(-/-) m

15 After intratracheal administration of adenoviral vectors expre

16 Clenoliximab) on immune functions following intratracheal administration of adenoviral vectors in mu

17 The intratracheal administration of AdMIP-1alpha resulted in

18 Intratracheal administration of AdRSVCGRP, followed by 1

19 Intratracheal administration of AdRSVeNOS attenuated the

20 odynamically, and animals were randomized to intratracheal administration of aerosolized AAV1 carryin

21 ic K-rasG12D allele that can be activated by intratracheal administration of an adenovirus expressing

22 cellular influx in the lung airway following intratracheal administration of an N-[1-(2-3-dioleyloxy)

23 lpha was induced in the lungs in response to intratracheal administration of Aspergillus fumigatus co

24 e to mainstream CS increases AHR after acute intratracheal administration of Aspergillus fumigatus ex

25 highly susceptible to lung injury caused by intratracheal administration of AV1-GFP, an early (E) re

26 Lung fibrosis was induced by intratracheal administration of BLEO (1 U/kg) to wild-ty

27 Intratracheal administration of bleomycin in wild-type a

28 Intratracheal administration of bleomycin led to caspase

29 F-beta1) is a critical mediator of ALI after intratracheal administration of bleomycin or Escherichia

30 A single intratracheal administration of CCL21 gene-modified dend

31 ved in antibacterial defenses, and exogenous intratracheal administration of CG combined with NE does

32 nes MIP-2 and KC were induced in response to intratracheal administration of conidia.

33 In anesthetized guinea pigs intratracheal administration of DEPs activated airway C-

34 Intratracheal administration of either SCW or SLO alone

35 Intratracheal administration of exogenous IFN-gamma to L

36 Intratracheal administration of GM-CSF induced final rAM

37 Two hours after intratracheal administration of HCl, W/D increased from

38 Intratracheal administration of IL-17 provoked a neutrop

39 ion of the lungs of CBA/J mice following the intratracheal administration of K. pneumoniae (7 x 10(2)

40 te that HFH-11 mRNA levels are stimulated by intratracheal administration of keratinocyte growth fact

41 In initial studies, we found that the intratracheal administration of Klebsiella pneumoniae in

42 Lung injury was induced by intratracheal administration of lipopolysaccharide (5 mg

43 Lung inflammation was induced with intratracheal administration of lipopolysaccharide (LPS)

44 Depletion of macrophages by the intratracheal administration of liposomal clodronate att

45 In this study, we report that intratracheal administration of LMW HA (200 kDa) causes

46 Intratracheal administration of low molecular mass (LMM)

47 Intratracheal administration of LPA in mice resulted in

48 Intratracheal administration of LPS (1 mg/kg) in WT mice

49 lation of neuraminidase (NA) 30 min prior to intratracheal administration of LPS increased polymorpho

50 phil accumulation in the airspaces following intratracheal administration of LPS.

51 nfections were initiated through noninvasive intratracheal administration of M. avium 724 in mice ind

52 Intratracheal administration of ManLAM in mice resulted

53 antly reduced in C57BL/6 mice after a single intratracheal administration of modified vectors, and le

54 ction could be achieved in the lung from the intratracheal administration of mRNA.

55 ct (HIV-LTR/luciferase (HLL)), we found that intratracheal administration of P. aeruginosa resulted i

56 bited augmented clearance 3 and 7 days after intratracheal administration of P. murina, which correla

57 nction of AM, C57BL/6 mice received low-dose intratracheal administration of pneumococci.

58 sceptible throughout 8 wk to infection after intratracheal administration of Pseudomonas aeruginosa;

59 The intratracheal administration of Pseudomonas to mice resu

60 Intratracheal administration of rat recombinant IL-18 in

61 Intratracheal administration of recombinant mouse comple

62 However, intratracheal administration of recombinant murine IL-12

63 er examined the effect of IGFBP-5 in vivo by intratracheal administration of replication-deficient ad

64 Intratracheal administration of SCP with either SCW or S

65 Intratracheal administration of silica was also able to

66 nhibition of Fas gene expression in lungs by intratracheal administration of small interfering RNA co

67 Intratracheal administration of SP-A to SP-A(-/-) mice e

68 Intratracheal administration of Sph3h was well tolerated

69 ospholipids were found to increase following intratracheal administration of tBuOOH (36 mg/kg), but n

70 expression of FcgammaRIIA in the lung after intratracheal administration of the AdFcgammaRIIA enhanc

71 Intratracheal administration of the natural antagonist o

72 Intratracheal administration of these agents concurrentl

73 rachea of wild-type and Cxcr2(-/-) mice, but intratracheal administration of TNFalpha did not induce

74 ts, pulmonary gene transfer was performed by intratracheal administration of various amounts of an ad

75 Intratracheal administration of Wnt3a or an antibody cap

76 experimental model used herein entailed six intratracheal administrations of methylnitrosourea (MNU)

77 Following intratracheal administration, OVA-specific CD4(+)CD25(+)

78 Their intratracheal administration resulted in increased airwa